Proprietary modified-release CTAP101 capsules are designed to raise prohormone serum total 25-hydroxyvitamin D concentrations to targeted levels (at least 30 ng/mL), while avoiding upregulation of a cytochrome P-450
The product is the generic version of Novartis’ Diovan HCT tablets designed to treat hypertension in patients uncontrolled with monotherapy or as primary therapy in patients likely to
EYLEA, which is formulated as an iso-osmotic solution, comprises portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1. The
The European Commission will review the CHMP’s positive opinion, based on the pivotal ARISTOTLE and AVERROES studies, and will make the final decision. The ARISTOTLE trial compared apixaban
The company claims that the new Prilosec OTC Wildberry, designed to be swallowed, offers similar heartburn relief as the Prilosec OTC. Procter & Gamble has begun the product
The company expects to launch Altrazeal in Austria in October 2012. Melmed Holdings chairman Helmut Kerschbaumer said the clinical and economic advantages that have been demonstrated are significant
Pursuant to the agreement, the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) will focus on identifying drug candidates from a program already receiving support from The Michael J.
The company has announced immediate shipment of the product. The generic version of Pfizer’s Antivert is indicated for the management of nausea and vomiting, and dizziness associated with
Quintiles Infosario solution integrates data, systems, processes and Quintiles’ therapeutic knowledge to have better-informed decisions from clinical trial planning and design, to trial execution services, through post-market outcome
The positive results from REV technology have induced the pharma company to actively participate in the testing program, which aims to refine the processes and seek FDA approval
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.